Respiratory: COPD Flashcards

1
Q

How is COPD diagnosed?

A

diagnosis is based on typical clinical features, confirmed with spirometry

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Who should COPD be suspected in?

A
  • age >35 with a risk factor eg smoking/environmental/occupational
  • plus one or more symptoms:
    -SOB - persistent, progressive, worse on exertion
  • chronic/recurrent cough
  • regular sputum production
  • frequent LRTIs
  • Wheeze
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What signs may be found on examination in COPD patients?

A
  • cyanosis
  • raised JVP +/- peripheral oedema (cor pulmonale)
  • cachexia
  • hyperinflation of chest
  • use of accessory muscles/pursed lip breathing
  • wheeze and/or crackles on chest auscultation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

When should alpha-1 antitrypsin deficiency be considered?

A
  • age <40
  • family Hx
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is cor pulmonale and what are the signs?

A
  • right heart failure secondary to lung disease. Caused by pulmonary hypertension due to hypoxia.
  • Signs:
    -peripheral oedema
    -raised JVP
  • systolic parasternal heave
  • loud second heart sound - over pulmonary valve (2nd left intercostal space)
  • hepatomegaly.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are the grades of the Medical Research Council (MRC) dyspnoea scale?

A

0 Not troubled by breathlessness except during strenuous exercise

1 Short of breath when hurrying or walking up a slight hill

2 Walks slower than contemporaries on the level because of breathlessness, or has to stop for breath when walking at own pace

3 Stops for breath after walking about 100 m or after a few minutes on the level

4 Too breathless to leave the house, or breathless when dressing or undressing

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Which investigations should be arranged in suspected COPD?

A
  • BMI
  • CXR (helps exclude lung cancer, TB, heart failure)
  • FBC - identify anaemia or polycythaemia
  • post-bronchodilator spirometry.

Others depend on situation:
* serial peak flow measurements if considering asthma.
* ECG & BNP ?heart failure
* CT thorax - if symptoms disproportionate to spirometry results- look for fibrosis/bronchiectasis (specialist advice)
* alpha 1 antitrypsin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What post-bronchodilator spirometry results indicate COPD?

A
  • post bronchodilator ratio of forced expiratory volume in 1 second (FEV1) to forced vital capacity (FVC) of less than 0.7. (FEV1/FVC <70%)

COPD should be considered in younger people with typical symptoms even if FEV1/FVC ratio is above 0.7.

Routine spirometry reversibility testing is not recommended.

Spirometry should be performed at diagnosis, when diagnosis reconsidered and for monitoring of disease severity and progression.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are the 4 stages of COPD airflow obstruction (staged by spirometry)?

A

-Severity is graded according to reduction in FEV1 compared to appropriate reference values (based on age, sex, height and ethnicity):
* Stage 1, mild — FEV1 80% of predicted value or higher.
* Stage 2, moderate — FEV1 50–79% of predicted value.
* Stage 3, severe — FEV1 30–49% of predicted value.
* Stage 4, very severe — FEV1 less than 30% of predicted value or FEV1 less than 50% with respiratory failure.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

When should asthma (or overlap) be considered in patient with possible COPD?

A
  • family history
  • other atopic disease
  • nocturnal or variable symptoms
  • is a non-smoker
  • onset of symptoms <35 years of age.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

How does an acute exacerbation of COPD present?

A
  • acute onset sustained worsening of a person’s symptoms from their usual stable state
  • can be triggered by: viral infection (rhinovirus), smoking, environment
    Commonly report:
  • Increased breathlessness
  • Increased cough
  • Increased sputum production and change in colour
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

When should someone with COPD be referred to respiratory?

A
  • ?lung cancer (eg haemoptysis or CXR features)
  • Unsure if asthma or fibrosis, or symptoms disproportionate to spirometry
  • very severe (FEV1 <30% predicted) or rapidly declining
  • ?cor pulmonale
  • <40/family Hx antitrypsin
  • frequent infections - assess preventable factors and ?bronchiectasis

To assess for :
* Oxygen
* Nebuliser
* Long term NIV
* Lung surgery

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

When should a patient be referred for pulmonary rehab?

A
  • MRC grade 3 or worse - functionally disabled by COPD
  • or recent hospital admission for Exacerbation

DO not refer if unable to walk or unstageable angina/recent MI

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

When should someone with COPD be referred to consider oxygen therapy?

A
  • Sats <=92% on air.
  • Very severe (forced expiratory volume in 1 second [FEV1] less than 30% predicted) or severe (FEV1 30–49% predicted) airflow obstruction.
  • Cyanosis.
  • Polycythaemia.
  • Peripheral oedema.
  • Raised jugular venous pressure.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What non-pharmacological treatments should be offered to COPD patients?

A
  • education, patient info
  • stop smoking support
  • pneumococcal and influenza vaccinations
  • pulmonary rehab (if indicated)
  • personalised self management plan.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is the stepwise pharmacological treatment for COPD?

A
  1. SABA or SAMA (short acting muscarinic antagonist - ipratropium- SAMA can be used if not on LAMA) to use as needed to relieve SOB and improve exercise tolerance
  2. If NO asthmatic features/steroid responsiveness: LABA plus LAMA (tiotrpoium). If ongoing symptoms affecting QOL despite this: 3 month trial of LABA+LAMA+ICS. If no improvement at 3 months, switch back to LABA+LAMA. If improved: continue triple therapy with annual review.
  3. If asthmatic features/steroid resonsiveness: LABA plus ICS. If ongoing symptoms affecting QOL/1 hospital admission/2 moderate exacerbations within a year: offer LABA+LAMA+ICS.
17
Q

What is the risk of using ICS in COPD?

A

Increased risk of pneumonia

18
Q

What add on treatments can be considered in COPD?

A
  • oral steroids (specialist)
  • oral theophylline (specialist)
  • oral mucolytic
  • Oral prophylactic macrolide (azithromycin) abx (specialist) - refer if >3 exacerbations needing steroids, and 1 needing hospital in the last year. Continue 6-12 months.
19
Q

How frequently should COPD patients be reviewed?

A
  • mild, moderate and severe COPD - once a year
  • Very severe COPD - twice a year.
20
Q

What should be checked at a COPD annual review?

A
  • symptom control and impact on life: use MRC scale.
  • Review inhalers and medication technique/adherence
  • smoking status
  • BMI
  • influenza/pnuemococcal vax
  • check for cor pulmonale, sleep apnoea, anxiety/depression
  • spirometry - check for decline in FEV1 and FVC. Loss of 500ml over 5 years - refer (rapid progression)
  • sats - consider if O2 therapy needed
21
Q

When should an acute exacerbation of COPD be sent to hospital?

A
  • severe SOB/ rapid onset
  • cannot cope at home/poor level of activity
  • confusion
  • sats <90% - give oxygen via 24% venturi mask at 2-3l/min. Aiming sats 88-92% in most.
  • cyanosis
  • worsening oedema
  • new arrhytmia
  • failure to respond to Rx
  • already on LTOT

hospital at home scheme may be available.

22
Q

What is the treatment for acute exacerbation of COPD in the community?

A
  • increase dose/frequency of SABA/SAMA (short acting bronchodilators)
  • 30mg pred for 5/7
  • ABX - increased sputum volume/thickness/change in colour. At risk of complications.
23
Q

Which ABX should be given for COPD acute exacerbation?

A
  • amoxicillin 500mg tds 5/7
  • or doxycycline 5/7
  • or clarithromycin 500mg BD 5/7

send sputum sample if no improvement after 3/7, and give alternative ABX

If at high risk Rx failure (resistance, frequent ABX, high risk comps) - consider co-amoxiclav. 625mg tds 5/7. (speciliast if unsure). Or co-trimoxazole
960mg BD (pen all.)

24
Q

When should rescue meds be prescribed for COPD patients to keep at home?

oral steorid & oral abx short course

A
  • an exacerbation in the last year, and remain at risk
  • understand when to take meds
  • Know when to seek help
25
Q

What suggests asthmatic features or steroid responsiveness in COPD patients?

A
  • any previous secure diagnosis of asthma or atopy,
  • a higher blood eosinophil count
  • substantial variation in FEV1 over time (at least 400 ml)
  • substantial diurnal variation in peak expiratory flow (at least 20%).
26
Q

In which group is COPD under-diagnosed?

A

age <45

27
Q

What ABG measurements indicate need for LTOT?

A
  • measured on 2 occasions
  • at least 3 weeks apart
  • give LTOT if PaO2 <7.3 kPa when stable
  • give if PaO2 <8kPa when assoc peripheral oedema, pulmonary HTN, secondary polycythaemia, nocturnal hypoxaemia, sats <92% on air
28
Q

What prescription of oxygen is started for LTOT?

A
  • at a flow rate to maintain PaO2 >8 kPa
  • flow rate 1litre/min initiated, then titrated up to 4litres/min
29
Q

How many hours a day should LTOT be prescribed for?

A
  • 15-24 hrs a dayfor optimum therapeutic benefit
30
Q

How should someone newly started on LTOT be reviewed?

A
  • F/U at 3 months
  • with repeat blood gases
  • review flow rate
  • ensure still indicated and therapeutic
  • then F/U every 6-12 months
31
Q

What are the spirometry findings in obstructive lung disease?

A
  • FEV1 - significantly reduced
  • FVC - reduced or normal
  • FEV1/FVC- reduced

Occurs with Asthma
COPD
Bronchiectasis
Bronchiolitis obliterans